The article entitled “Statins enhance trastuzumab deruxtecan efficacy: preclinical synergy in HER2-negative models and clinical benefit in HER2-positive metastatic breast cancer (https://doi.org/ 10.1186/s40164-026-00787-z)”, authored by Prof. Dr. Ozan Yazıcı, a faculty member in the Department of Internal Medicine, Faculty of Medicine, and colleagues, was published in Experimental Hematology & Oncology, which is among the top 500 journals in SCI-Exp and has a WoS impact factor of 17.5.

We congratulate them for their university-collaborative publications and wish them continued success.